DEMO Pharmaceuticals launches R&D hub in Thessaloniki

DEMO Pharmaceuticals launches R&D hub in Thessaloniki

DEMO Pharmaceuticals has launched a new research and development center, one of the largest in Greece, in the northern port city of Thessaloniki.

The facility forms part of the industry’s 356-million-euro investment plan for the 2021-2027 period. The Greek pharma company intends to develop five pharmaceutical substances and 21 final products at the R&D hub, which covers 2,400 square meters and employs 100 researchers for now, expanding to 200 later on.  

Chief Executive Dimitris Demos explained that the investment had originally been planned for a decade ago but was delayed by the economic crisis. T

he expertise that will be developed at the hub will feed DEMO’s new facilities in Tripoli in order to produce raw materials in Greece, a move that, according to the company’s management, is also in line with the new European pharmaceutical strategy for reducing dependence on third countries.


Subscribe to our Newsletters

Enter your information below to receive our weekly newsletters with the latest insights, opinion pieces and current events straight to your inbox.

By signing up you are agreeing to our Terms of Service and Privacy Policy.